Biogen Trial Transparency
Study Detail Header
/ / 273CH301
Efficacy and Safety of BIIB111 for the Treatment of Choroideremia
PLS AVAILABLE
Study Identifier273CH301
Clinicaltrials.gov
#NCT03496012
Details
Development Status
Discontinued
Study Type
Interventional
Results Available
Yes
Study Dates
12/2017 - 12/2020
Enrollment
169
Study Drug
BIIB111
Summary
The objective of the study is to evaluate the efficacy and safety of a single sub-retinal injection of BIIB111 in participants with choroideremia (CHM).
Study Results
View and download the Results Summaries with the results of this completed study.
PDF
CSR Synopsis
PDF Document
PDF
Plain Language Summary
PDF Document
View study results on registries